Kenneth Cartwright

Randomized Trial of an Inhibitor of Formation of Advanced Glycation End Products in Diabetic Nephropathy

W. Kline Bolton, Daniel C. Cattran, Mark E. Williams et al. · American Journal of Nephrology · 2004 · 448 citations

Hemoglobin-AGE: A Circulating Marker of Advanced Glycosylation

Zenji Makita, Helen Vlassara, Elliot J. Rayfield et al. · Science · 1992 · 253 citations

Aging, Glycobiology, Metabolic Syndrome +18

Design and Baseline Characteristics for the Aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II)

B. I. Freedman, Jean-Paul Wuerth, Kenneth Cartwright et al. · Controlled Clinical Trials · 1999 · 250 citations

Diabetes Management, Renal Function, Renal Disease +10

Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer.

I. Craig Henderson, Joseph C. Allegra, Thomas Woodcock et al. · Journal of Clinical Oncology · 1989 · 247 citations

Randomized Clinical Trial, Metastatic Breast Cancer, Breast Oncology +11

Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Lederle Cooperative Group.

Z Arlin, Delvyn C. Case, J. Moore et al. · PubMed · 1990 · 199 citations